AJP - Cell Physiology, Vol 267, Issue 1 C236-C244, Copyright © 1994 by American Physiological Society

ARTICLES

Regulation of calcium mobilization and entry in human platelets by endothelium-derived factors

J. Geiger, C. Nolte and U. Walter
Medizinische Universitatsklinik, Klinische Forschergruppe, Universitat Wurzburg, Germany.

Stimulation of Ca2+ mobilization and entry by agonists such as ADP, thrombin, and thromboxane is an early step of platelet activation. Here, we compared the effects of adenosine 3',5'-cyclic monophosphate (cAMP)-elevating prostaglandins, guanosine 3',5'-cyclic monophosphate (cGMP)-elevating nitrovasodilators, membrane-permeant selective activators of cAMP- or cGMP-dependent protein kinases, and physiological endothelium-derived factors on the agonist-evoked Ca2+ mobilization and entry in human platelets. Prostaglandin E1, the prostacyclin analogue Iloprost, the nitric oxide (NO) donor 3-morpholinosydnonimine hydrochloride, and selective activators of cGMP- or cAMP-dependent protein kinase strongly inhibited the agonist-evoked Ca2+ mobilization from intracellular stores and associated late Ca2+ entry but had little effects on the rapid (1st) phase of ADP-evoked Ca2+ entry. During coincubation of platelets with endothelial cells, endothelium-derived factors that were released strongly inhibited platelet agonist-evoked Ca2+ mobilization and only moderately affected the rapid phase of ADP-evoked Ca2+ entry. These effects were partially prevented when endothelial cells were preincubated with cyclooxygenase and/or NO synthase inhibitors. Endothelial cells therefore produce sufficient quantities of labile platelet inhibitors whose effects on the platelet Ca2+ response resemble those observed with selective cAMP- and cGMP-dependent protein kinase activators.

This article has been cited by other articles:

				M. T Gewaltig and G. Kojda Vasoprotection by nitric oxide: mechanisms and therapeutic potential Cardiovasc Res, August 1, 2002; 55(2): 250 - 260. [Abstract] [Full Text] [PDF]

				S. S. El-Daher, Y. Patel, A. Siddiqua, S. Hassock, S. Edmunds, B. Maddison, G. Patel, D. Goulding, F. Lupu, R. J. H. Wojcikiewicz, et al. Distinct localization and function of 1,4,5IP3 receptor subtypes and the 1,3,4,5IP4 receptor GAP1IP4BP in highly purified human platelet membranes Blood, June 1, 2000; 95(11): 3412 - 3422. [Abstract] [Full Text] [PDF]

				N. N. Kahn Platelet-stimulated thrombin and PDGF are normalized by insulin and Ca2+ channel blockers Am J Physiol Endocrinol Metab, May 1, 1999; 276(5): E856 - E862. [Abstract] [Full Text] [PDF]

				P. Minuz, G. Andrioli, M. Degan, S. Gaino, R. Ortolani, R. Tommasoli, V. Zuliani, A. Lechi, and C. Lechi The F2-Isoprostane 8-Epiprostaglandin F2{alpha} Increases Platelet Adhesion and Reduces the Antiadhesive and Antiaggregatory Effects of NO Arterioscler. Thromb. Vasc. Biol., August 1, 1998; 18(8): 1248 - 1256. [Abstract] [Full Text] [PDF]